Lindbrook Capital’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $16.7K | Buy |
566
+26
| +5% | +$768 | ﹤0.01% | 1433 |
|
|
2024
Q4 | $15.7K | Sell |
540
-69
| -11% | -$2.01K | ﹤0.01% | 1422 |
|
|
2024
Q3 | $28K | Buy |
609
+18
| +3% | +$827 | ﹤0.01% | 1106 |
|
|
2024
Q2 | $24.1K | Buy |
591
+89
| +18% | +$3.64K | ﹤0.01% | 1132 |
|
|
2024
Q1 | $12.8K | Hold |
502
| – | – | ﹤0.01% | 1432 |
|
|
2023
Q4 | $4.54K | Buy |
502
+15
| +3% | +$136 | ﹤0.01% | 1933 |
|
|
2023
Q3 | $3.11K | Buy |
487
+329
| +208% | +$2.1K | ﹤0.01% | 1967 |
|
|
2023
Q2 | $1.75K | Buy |
158
+19
| +14% | +$211 | ﹤0.01% | 2201 |
|
|
2023
Q1 | $2.13K | Sell |
139
-9
| -6% | -$138 | ﹤0.01% | 2218 |
|
|
2022
Q4 | $3.28K | Buy |
148
+132
| +825% | +$2.93K | ﹤0.01% | 2010 |
|
|
2022
Q3 | $0 | Hold |
16
| – | – | ﹤0.01% | 2887 |
|
|
2022
Q2 | $0 | Sell |
16
-236
| -94% | – | ﹤0.01% | 2749 |
|
|
2022
Q1 | $5K | Buy |
+252
| New | +$5K | ﹤0.01% | 1609 |
|